A study has found a previously known cancer-related drug aka nivolumab/relatlimab can be repurposed for Parkinson's disease, ...

Parkinson's disease (PD) is a widespread neurological ailment that is becoming more prevalent as the world's population ages. It is estimated that approximately 10 million people worldwide are ...

For decades, medical understanding of Parkinson’s disease focused exclusively on the brain, specifically the death of dopamine-producing neurons that control movement. This narrow view shaped ...

Parkinson's and Alzheimer's diseases are the two most common neurodegenerative disorders, affecting millions of people ...

Parkinson’s disease is a neurodegenerative disorder that causes a gradual loss of brain nerve cells, which produce a chemical messenger called dopamine. Dopamine relays signals throughout the brain ...

Some doctors say the chemicals all around us may be increasing our risk of Parkinson’s disease, the fastest-growing neurodegenerative disorder in the world.

Symptoms of Parkinson’s disease, which afflicts around 1 million Americans, usually begin gradually and worsen over time.

Researchers have uncovered a shared brain cell breakdown mechanism behind Alzheimer’s and Parkinson’s diseases, revealing how ...